Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7OJO

Tankyrase 2 in complex with two small molecule fragments

これはPDB形式変換不可エントリーです。
7OJO の概要
エントリーDOI10.2210/pdb7ojo/pdb
分子名称Poly [ADP-ribose] polymerase tankyrase-2, quinazolin-4(3H)-one, 4-acetamido-~{N}-(2-methoxyphenyl)benzamide, ... (7 entities in total)
機能のキーワードinhibitor, complex, poly-adp-ribosylation, enzyme, transferase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数4
化学式量合計51260.29
構造登録者
Sowa, S.T.,Lehtio, L. (登録日: 2021-05-17, 公開日: 2022-06-01, 最終更新日: 2025-06-25)
主引用文献Sowa, S.T.,Kucukdisli, M.,Mostinski, Y.,Schaller, D.A.,Vinagreiro, C.S.,Cirillo, D.,Bosetti, C.,Brinch, S.A.,van Laar, K.,Wegert, A.,Leenders, R.G.G.,Krauss, S.,Waaler, J.,Volkamer, A.,Lehtio, L.,Nazare, M.
Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization.
J.Med.Chem., 68:7263-7279, 2025
Cited by
PubMed Abstract: Designing inhibitors is a complex task that requires a deep understanding of protein-ligand interactions and their dynamics. Ligands often interact with multiple binding subsites, with noncovalent interactions affecting binding affinity. Conformational changes and plasticity of both, the ligand and the protein influence binding energetics. We investigated the tankyrase ADP-ribosyltransferase as a promising drug target regulating many cellular pathways. Despite the existence of diverse tankyrase inhibitors, their binding energetics and contributions of flexible cryptic subpockets to binding affinity remain elusive. To examine these aspects, we deconstructed inhibitors to key fragments, dissected their energetic contribution to the affinity, and determined their binding mode by X-ray crystallography. Varying ligand efficiencies of the deconstructed, pocket-binding fragments revealed the cryptic nature of subpockets. These insights enabled us to redesign inhibitors with novel linkers, the observed key area for optimization, increasing the potency in enzymatic and cell-based assays by 7.5-fold and 6.2-fold compared to the parent ligand.
PubMed: 40134122
DOI: 10.1021/acs.jmedchem.4c02845
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 7ojo
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon